Altimmune Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
15 Aug 23 | BuyUS$863 | David Drutz | Individual | 300 | US$2.88 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 10,604 | 0.015% |
Individual Insiders | 550,266 | 0.776% |
General Public | 25,757,715 | 36.3% |
Institutions | 44,576,701 | 62.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 43.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,649,270 | US$63.1m | 753% | no data | |||
4,183,682 | US$30.5m | 38,300% | 0.01% | |||
4,044,707 | US$29.5m | 6.81% | no data | |||
3,571,972 | US$26.1m | 6.81% | no data | |||
2,911,937 | US$21.3m | 1,570% | 0.02% | |||
2,750,000 | US$20.1m | 0% | 2.03% | |||
1,720,637 | US$12.6m | -50.1% | no data | |||
1,391,485 | US$10.2m | 2,910% | 0.02% | |||
1,193,528 | US$8.7m | 13.3% | no data | |||
940,451 | US$6.9m | 727% | 0.01% | |||
809,095 | US$5.9m | 2,600% | 12.14% | |||
723,484 | US$5.3m | 4,780% | no data | |||
608,919 | US$4.4m | 17,600% | no data | |||
580,444 | US$4.2m | 885% | no data | |||
547,441 | US$4.0m | 229% | 0.12% | |||
473,829 | US$3.5m | 5.2% | no data | |||
455,532 | US$3.3m | 1,010% | no data | |||
432,341 | US$3.2m | 0% | 0.01% | |||
412,858 | US$3.0m | 57.7% | no data | |||
399,357 | US$2.9m | 0% | 0.19% | |||
341,000 | US$2.5m | -65.6% | 0.5% | |||
326,777 | US$2.4m | 0% | no data | |||
326,658 | US$2.4m | 0% | 0.01% | |||
307,318 | US$2.2m | 0% | 0.4% | |||
304,650 | US$2.2m | 0% | 0.05% |